- High gross margin of 99.8%
- Low bankruptcy risk (Altman Z-Score: 8.79)
- Lower volatility than the market (beta 0.51)
Coya Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on Jul 31, 2026)
The Coya Therapeutics, Inc. stock price gained 2.70% on the last trading day (Friday, 31st Jul 2026), rising from $4.08 to $4.19. During the last trading day the stock fluctuated 5.13% from a day low at $4.00 to a day high of $4.21. The price has been going up and down for this period, and there has been a -7.71% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 26 thousand more shares were traded than the day before. In total, 177 thousand shares were bought and sold for approximately $742.15 thousand.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.88 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.90% during the next 3 months and, with a 90% probability hold a price between $3.99 and $6.31 at the end of this 3-month period.
COYA Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 8.27%. Further rise is indicated until a new top pivot has been found. Coya Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Coya Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.93. On a fall, the stock will find some support from the short-term average at $4.15. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Coya Therapeutics, Inc. stock
Coya Therapeutics, Inc. finds support from accumulated volume at $4.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.205 between high and low, or 5.13%. For the last week, the stock has had daily average volatility of 5.40%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (COYA) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Coya Therapeutics, Inc. to open at $4.13, and during the day (based on 14 day Average True Range), to move between $4.05 and $4.33, which gives a possible trading interval of +/-$0.288 (+/-7.12%) up or down from last closing price. If Coya Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.12% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $4.11 (1.91%) than the resistance at $4.29 (2.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Coya Therapeutics, Inc. stock A Buy?
Coya Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.162
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $4.13 ( 1.39%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
COYA Performance
Trading levels for COYA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.34 | 3.50% |
| R2 | 4.26 | 1.63% |
| R1 | 4.21 | 0.477% |
| Price | 4.19 | |
| S1 | 4.05 | -3.26% |
| S2 | 4.00 | -4.42% |
| S3 | 3.93 | -6.28% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.87 | 16.23% |
| R2 | 4.54 | 8.35% |
| R1 | 4.29 | 2.39% |
| Price | 4.19 | |
| S1 | 4.11 | -1.91% |
| S2 | 4.08 | -2.63% |
| S3 | 4.00 | -4.53% |
FAQ
Click here for our free guide on how to buy Coya Therapeutics, Inc. Stock.
Buy COYA